Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

This publication has 29 references indexed in Scilit:

• Biological basis of anemia
  Seminars in Oncology, 2001
• Bias in meta-analysis detected by a simple, graphical test
  BMJ, 1997
• Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
  American Journal of Kidney Diseases, 1995
• Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis
  Australian and New Zealand Journal of Medicine, 1991
• Low-Dose Recombinant Human Erythropoietin Therapy in Chronic Hemodialysis Patients
  American Journal of Kidney Diseases, 1991
• Treatment of Transfusion-Dependent Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: A European multicentre study in 142 patients to define dose regimen and safety profile
  Nephrology Dialysis Transplantation, 1991
• Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
  BMJ, 1990
• Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
  Annals of Internal Medicine, 1989
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986
• The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
  Medical Care, 1981